DAVID GRANOVSKY

Posts Tagged ‘act’

Advanced Cell Technology Announces Proxy Results | Reuters

In BUSINESS OF STEM CELLS on September 16, 2009 at 2:33 pm

WORCESTER, Mass.–(Business Wire)– Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) announced today that shareholders have approved each proposal in the Company`s proxy statement dated August 5, 2009.

As a result, the 2005 Stock Incentive Plan has been amended to increase the total number of shares available for issuance and the certificate of incorporation has been amended to increase the authorized shares eligible for issuance by the Company.

“We are pleased that shareholders have elected to approve each of the proposals in the proxy, supporting the Company`s efforts to further develop its stem cell technology platform,” said William M. Caldwell IV, the Company`s Chairman and Chief Executive Officer.

“We remain focused on submitting an IND for the RPE program to the FDA for approval to commence a Phase I Clinical Trial prior to the end of the year.”

via Advanced Cell Technology Announces Proxy Results | Reuters.

Are you or a loved one interested in receiving stem cell treatment? For free treatment information, please fill out our treatment form or email don@repairstemcells.org and just put Therapy in the subject box.

The ADA is Confused about Embryonic Stem Cell Potential

In ALL ARTICLES on September 8, 2009 at 10:51 pm

The ADA (American Diabetes Association) has influence over their 70,000 members, the 350,000 people who contacted them over the past year and the nearly 24 million children and adults in the U.S. with diabetes their advocacy efforts support…

That is why it is so sad to see them placing all of their hope on embryonic stem cell research.
Excerpted from the original article:
“The Stem Cell Research Enhancement Act, also known as H.R.3… would ease up on the existing restrictions on embryonic stem cell research… The American Diabetes Association knows that the passing of this act is the best hope humans have for advancement in the cure for Diabetes.”

Here is a only a small collection of articles that show that ADULT stem cells are the REAL and CURRENT and BEST hope humans have for advancement in the cure for Diabetes.

Stem Cells + Hyperbaric Improve Diabetes type 2 – http://wp.me/prcQV-1dc

Insulin-Producing Cells From Adult Skin Cells – http://wp.me/prcQV-1da

Can stem cells cure Diabetes – type 2? – http://wp.me/prcQV-1cU

Can stem cells cure Diabetes – type 1? – http://wp.me/prcQV-1cJ

…………………
To read the original article:

Stem Cell Research Enhancement Act Relating to Diabetes.

No more drive-through mastectomies!

In ALL ARTICLES, OFF THE BEATEN PATH on May 27, 2009 at 2:02 pm

breast reconstruction

Proposed Mastectomy Law Change
(written by a surgeon)
;

I’ll never forget the look in my patients eyes when I had to tell them they had to go home with the drains, new exercises and no breast. I remember begging the doctors to keep these women in the hospital longer, only to hear that they would, but their hands were tied by the insurance companies.

So there I sat with my patient giving them the instructions they needed to take care of themselves, knowing full well they didn’t grasp half of what I was saying, because the glazed, hopeless, frightened look spoke louder than the quiet ‘Thank you’ they muttered.

A mastectomy is when a woman’s breast is removed in order to remove cancerous breast cells/tissue. If you know anyone who has had a mastectomy, you may know that there is a lot of discomfort and pain afterwards. Insurance companies are trying to make mastectomies an outpatient procedure. Let’s give women the chance to recover properly in the hospital for 2 days after surgery.

This Mastectomy Bill is in Congress now. It takes 2 seconds to do this and is very important. Please take the time and do it really quick! The Breast Cancer Hospitalization Bill is important legislation for all women.

Please send this to everyone in your address book. If there was ever a time when our voices and choices should be heard, this is one of those times. If you’re receiving this, it’s because I think you will take the 30 seconds to go to vote on this issue and send it on to others you know who will do the same.

There’s a bill called the Breast Cancer Patient Protection Act which will require insurance companies to cover a minimum 48-hour hospital stay for patients undergoing a mastectomy. It’s about eliminating the ‘drive-through mastectomy’ where women are forced to go home just a few hours after surgery, against the wishes of their doctor, still groggy from anesthesia and sometimes with drainage tubes still attached.

Lifetime Television has put this bill on their web page with a petition drive to show your support.. Last year over half the House signed on. PLEASE! Sign the petition by clicking on the web site below. You need not give more than your name and zip code number.

http://www.mylifetime.com/community/my-lifetime-commitment/breast-cancer/petition/breast-cancer-petition

This takes about 2 seconds. PLEASE PASS THIS ON to your 20 friends.

breast cancer cell 7

breast cancer cell

“STEM CELLS SUCCESSFULLY TREAT PATIENTS” SAYS CONGRESSIONAL DESK!

In ALL ARTICLES, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on February 16, 2009 at 2:34 am

“Today, considerable progress has been made in adult stem cell research, including the successful use of stem cells derived from human skin cells, wisdom teeth, and umbilical cord blood. These cells have been used to successfully treat patients who had suffered from Type 1 Diabetes, Leukemia and other forms of cancer, Parkinson´s Disease, Alzheimer´s, and heart diseases, while maintaining ethical standards.”

Congressional Desk -February 15, 2009

Washington, D.C. – Congressman J. Randy Forbes (VA-04), along with Congressman Daniel Lipinski (IL-03), today announced that they have reintroduced the Patients First Act, H.R. 877, in the 111th Congress. The bill would intensify research and human clinical trials using stem cells that are ethically obtained and that show evidence of providing near-term clinical benefit for human patients. Additionally, the legislation would promote the creation of pluripotent stem cell lines without the creation, destruction, or discarding of human embryos.

“Even just in recent weeks, we have seen the debate over stem cell research become increasingly more divisive. However, when human lives are at stake, divisiveness is not a luxury we can afford. Advancing scientific development and protecting life do not have to be opposing forces. The Patients First Act allows us to put the political debate aside, unlock the potential in adult stem cell research, and focus on the common goal on both sides of the stem cell debate – curing and treating patients,” said Forbes.

“The Patients First Act offers hope for millions of Americans,” said Lipinski. “This bill bridges the political divide by focusing our energies on the common goal of finding cures for diseases like diabetes, and it does so without having to choose between advancing medicine and contentious life issues. As someone who has lived with juvenile diabetes for almost twenty years, I am proud to once again help introduce this important legislation.”

Today, considerable progress has been made in adult stem cell research, including the successful use of stem cells derived from human skin cells, wisdom teeth, and umbilical cord blood. These cells have been used to successfully treat patients who had suffered from Type 1 Diabetes, Leukemia and other forms of cancer, Parkinson´s Disease, Alzheimer´s, and heart diseases, while maintaining ethical standards.

The Patients First Act would specifically:

Promote the creation of pluripotent stem cell lines without the creation, destruction and discarding of, or risk of injury to human embryos;

Intensify stem cell research that may result in an improved understanding of, or treatment for, diseases and other adverse health conditions;

Promote research and human clinical trials using stem cells that are ethically obtained and show evidence of providing clinical benefit for human patients; and,

Direct the National Institutes of Health to prioritize stem cell research that has the greatest potential for near-term clinical benefits, by directing both basic and clinical research towards what is currently showing benefits in treating patients now.

The Patients First Act was originally introduced in the 110th Congress as H.R. 2807. The bill currently has 13 cosponsors and has been referred to the House Committee on Energy and Commerce where it awaits further action.

via American Chronicle | Forbes, Lipinski Reintroduce Bipartisan Stem Cell Bill.

%d bloggers like this: